Changes in Antibody Titers of Measles, Mumps, Rubella, and Hepatitis B Virus AftEr Bone Marrow Transplantation in Korea: A Preliminary Report / 감염
Korean Journal of Infectious Diseases
; : 558-563, 1998.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-75554
Biblioteca responsável:
WPRO
ABSTRACT
BACKGROUND:
Bone marrow transplantation (BMT) has become a significant treatment modality for hematopoietic and solid organ malignancy. Recipients of BMTs lose immunity to measles-mumps-rubella (MMR) and hepatitis B infections which are preventable with vaccination. There is no consensus regarding a vaccination schedule after BMT and time of vaccination is variable according to each institution. We analyzed sequential changes in antibody titers of MMR and hepatitis B during the first year after BMT in an attempt to identify the time, dose, and needs for revaccination.METHODS:
Total 20 patients with hematologic malignancies were studied. Serum levels of IgG antibodies of MMR and hepatitis B virus (HBV) were determined every three months post-BMT by enzyme immunoassay (EIA), chemical luminescence immunoassay (CLIA) and immunofluorescence assay (IFA).RESULTS:
IgG antibody levels of measles, rubella, HBV were 1746, 80 85 IU/mL, 214 343 IU/L before BMT, declined to 1633, 18 11 IU/mL, 4 6 IU/L one year after BMT, respectively. All the antibody levels were still above cut-off value for positive immunity. Mumps antibody titers were 162 before BMT, declined to 125 significantly from 6 months after BMT, but the antibody level was still above cut-off value.CONCLUSION:
Antibody titers of MMR and hepatitis B decline during the first year after BMT, but the levels are still above cut-off value. Thus, the timing of revaccination should be after the first year post-transplantation. Long-term studies are needed to determine the optimal time for revaccination.
Texto completo:
Disponível
Contexto em Saúde:
ODS3 - Saúde e Bem-Estar
/
ODS3 - Meta 3.3 Acabar com as doenças tropicais negligenciadas e combater as doenças transmissíveis
Problema de saúde:
Meta 3.3: Acabar com as doenças tropicais negligenciadas e combater as doenças transmissíveis
/
Meta 3.4: Reduzir as mortes prematuras devido doenças não transmissíveis
/
Hepatite
/
Sarampo
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Agendamento de Consultas
/
Rubéola (Sarampo Alemão)
/
Medula Óssea
/
Imunoglobulina G
/
Imunoensaio
/
Vírus da Hepatite B
/
Imunofluorescência
/
Técnicas Imunoenzimáticas
/
Transplante de Medula Óssea
/
Imunização Secundária
Tipo de estudo:
Guia de prática clínica
Limite:
Humanos
País/Região como assunto:
Ásia
Idioma:
Coreano
Revista:
Korean Journal of Infectious Diseases
Ano de publicação:
1998
Tipo de documento:
Artigo